Core Viewpoint - HSBC Holdings and Hang Seng Bank have announced a proposal for the privatization of Hang Seng Bank, with a cash offer of HKD 155.00 per share, representing a premium of approximately 30.3% over the last closing price of HKD 119.00 [1][2] Group 1: Privatization Proposal - HSBC Asia Pacific, as the offeror, has requested the Hang Seng Bank board to present the proposal to shareholders for privatization under Section 673 of the Companies Ordinance [1] - The proposed cash consideration will be paid to shareholders for all issued shares of Hang Seng Bank, excluding certain shares held by HSBC Asia Pacific [1][2] - Shareholders will receive an interim dividend for the third quarter of 2025, which will not be deducted from the proposed cash consideration [1] Group 2: Financial Implications - HSBC Asia Pacific will utilize internal resources to pay the proposed cash consideration to shareholders, with BofA Securities and Goldman Sachs confirming sufficient financial resources for this payment [3] - The proposal is expected to enhance earnings per share by eliminating non-controlling interest deductions from Hang Seng Bank's profits [3] - HSBC aims to maintain a dividend payout ratio of 50% of earnings per share, excluding significant items, and anticipates a capital impact of approximately 125 basis points upon completion of the proposal [3]

Core Viewpoint - Changhong Jiahua (03991) has resumed trading with a significant increase of nearly 23%, following the announcement of a privatization plan by the offeror, Hongtu Investment Co., Ltd. [1] Group 1: Stock Performance - The stock opened high at approximately 23% and is currently up 22.83%, trading at HKD 1.13 with a transaction volume of HKD 655,400 [1]. Group 2: Privatization Plan - Changhong Jiahua and Hongtu Investment Co., Ltd. announced a plan to privatize the company, which will be presented to shareholders for approval by September 22, 2025 [1]. - If approved, the plan will lead to the delisting of the company's ordinary shares from the Hong Kong Stock Exchange [1]. - The proposed plan includes a buyout price of HKD 1.223 per share, representing a premium of approximately 32.93% over the last trading day's closing price of HKD 0.920 [1]. Group 3: Shareholder Structure - As of the announcement date, there are approximately 580 million ordinary shares, with a total valuation of about HKD 709 million [1]. - The offeror is a special purpose company directly owned by Changhong Group, which is controlled by the Mianyang State-owned Assets Supervision and Administration Commission and the Sichuan Provincial Finance Department [1]. - Changhong Group, as the largest single shareholder of Sichuan Changhong, effectively controls the majority of the board members of Sichuan Changhong [1].

Core Viewpoint - Sichuan Changhong's subsidiary, Changhong Jiahua, is set to be privatized by its controlling shareholder, Changhong Holdings Group, through its wholly-owned subsidiary, Hongtu Investment, which will acquire the remaining shares not controlled by Sichuan Changhong [2][5]. Group 1: Privatization Details - The privatization plan involves the acquisition of approximately 580 million ordinary shares held by other shareholders, representing about 39.87% of Changhong Jiahua's total ordinary shares and 22.57% of its total issued ordinary and convertible preferred shares [5]. - The proposed price for each share is HKD 1.223, totaling approximately HKD 709 million, which represents a premium of about 32.93% over the last trading day's closing price of HKD 0.920 [6]. - The average closing prices for the last 10, 30, 90, and 180 trading days were HKD 0.911, HKD 0.924, HKD 0.881, and HKD 0.764, with respective premiums of approximately 34.25%, 32.36%, 38.78%, and 60.17% [6]. Group 2: Business Context - Changhong Jiahua is a significant subsidiary of Sichuan Changhong, primarily engaged in ICT products, solutions, and digital intelligent comprehensive services [5]. - Since its restructuring and listing in 2013, Changhong Jiahua has experienced low trading volume, stock price, and liquidity, which have not improved despite its listing on the Hong Kong main board [5]. - The privatization aims to reduce listing-related costs and leverage the overall resources of Changhong Holdings Group for new development opportunities [5]. Group 3: Industry Trends - In recent years, several state-owned enterprises have completed the privatization of their Hong Kong-listed companies, indicating a trend towards consolidating operations and improving business efficiency [7]. - The State-owned Assets Supervision and Administration Commission has encouraged the disposal of underperforming listed companies through mergers and asset restructuring [8].

Core Viewpoint - Sichuan Changhong Electric Co., Ltd. plans to privatize its subsidiary, Changhong Jiahua Holdings Limited, through a scheme proposed by its controlling shareholder, Changhong Electronics Holding Group Co., Ltd. This move aims to enhance operational efficiency and reduce costs associated with being publicly listed [2][7]. Summary by Sections Privatization Overview - Changhong Jiahua, a significant subsidiary of Sichuan Changhong, will be privatized by its controlling shareholder's wholly-owned subsidiary, Hongtu Investment Co., Ltd. The plan involves acquiring all issued ordinary shares of Changhong Jiahua, excluding those controlled by Sichuan Changhong, leading to the delisting of Changhong Jiahua from the Hong Kong Stock Exchange [2][5]. - The privatization plan has received a no-objection letter from the Hong Kong Securities and Futures Commission [2][6]. Financial and Shareholding Structure - As of now, Changhong Jiahua has issued 1,454,652,000 ordinary shares and 1,115,868,000 convertible preferred shares. Sichuan Changhong indirectly holds 874,650,000 ordinary shares, representing 60.13% of the total ordinary shares [5]. - The privatization will involve the acquisition of 580,002,000 ordinary shares from other shareholders, which constitutes approximately 39.87% of Changhong Jiahua's ordinary shares and 22.57% of its total issued shares [5][7]. Impact on Company and Subsidiary - The privatization is expected to have no significant impact on the financial status or operations of Sichuan Changhong, as its ownership percentage in Changhong Jiahua will remain unchanged [7]. - The long-term underperformance of Changhong Jiahua's stock price has hindered its ability to leverage the Hong Kong stock market for capital operations, making privatization a strategic move to reduce listing costs and explore new growth opportunities [7][9]. Board Approval and Procedures - The privatization proposal was approved by the board of directors during the 36th meeting of the 12th board session, with a voting outcome of 4 in favor and 5 abstentions [19][20]. - The board's decision does not require shareholder approval as per the company's articles of association [14]. Future Arrangements - Following the completion of the privatization, Hongtu Investment will become a minority shareholder of Changhong Jiahua, and the company will continue to provide necessary financial support as per regulatory requirements [10][12].

Core Viewpoint - Changhong Jiahua (03991) and the offeror Hongtu Investment Co., Ltd. announced a privatization plan that, if approved, will lead to the delisting of the company's ordinary shares from the stock exchange [1] Summary by Relevant Sections Privatization Proposal - The offeror has entered into an implementation agreement with the company, proposing to present a plan to shareholders for privatization [1] - If the plan is approved, all plan shares will be canceled in exchange for a price of HKD 1.223 per share, representing a premium of approximately 32.93% over the last trading price of HKD 0.920 per share [1] Share Valuation - As of the announcement date, there are approximately 580 million ordinary shares involved in the plan, with a total estimated valuation of about HKD 709 million [1] Ownership Structure - The offeror is a special purpose company directly owned by Changhong Group, which is controlled by the State-owned Assets Supervision and Administration Commission of Mianyang City and the Sichuan Provincial Finance Department [1] - Changhong Group, as the largest single shareholder of Sichuan Changhong, effectively controls the composition of the board of directors [1]

Core Viewpoint - The proposed transaction involves the distribution of Lantu shares to existing shareholders and a merger agreement between Dongfeng Motor Group and Dongfeng Motor Group (Wuhan) Investment Co., aiming to privatize the remaining business and enhance shareholder value through the listing of Lantu on the Hong Kong Stock Exchange [1][2]. Group 1: Proposed Transaction Details - The company has resolved to distribute its Lantu shares to existing shareholders, with Lantu applying for a listing on the Hong Kong Stock Exchange, contingent upon the distribution conditions being met [1]. - H-share shareholders will receive 0.3552608 Lantu H-shares for each H-share held on the record date, along with a cash cancellation price of HKD 6.68 per H-share [2]. - The theoretical total value per H-share in the proposed transaction is approximately HKD 10.85, representing a premium of about 128.90% over the last unaffected trading price of HKD 4.74 [2]. Group 2: Strategic Objectives - The merger aims to further integrate quality resources towards emerging industries, focusing on the development of the new energy vehicle sector and transitioning from fuel vehicles to electric vehicles [3]. - The listing of Lantu is expected to broaden financing channels, enhance brand image, expand overseas operations, and improve corporate governance [3]. Group 3: Market Activity - The company has applied to the Stock Exchange for the resumption of trading of H-shares starting from 9:00 AM on August 25, 2025 [4]. - Dongfeng Company is primarily engaged in the manufacturing and supply of commercial vehicles, passenger vehicles, and electric vehicles, along with related services and products [4].

Core Viewpoint - Kangji Medical Holdings Limited plans to initiate a privatization delisting process with an overall valuation of approximately HKD 11.2 billion [2] Group 1: Privatization Details - The privatization is initiated by a consortium led by founder Zhong Ming, along with Shentu Yinguang, global private equity giant TPG, TPG's NewQuest V Fund, and Qatar Investment Authority's Al-Rayyan Holding [5] - The proposed share cancellation price is HKD 9.25 per share, representing a 21.7% premium over the closing price of HKD 7.6 on June 30, 2025, and exceeding the highest closing price of HKD 8.66 since 2022 [5] - Upon completion of the transaction, Kangji Medical will become a wholly-owned subsidiary of the offeror and will delist from the Hong Kong Stock Exchange [5] Group 2: Financial and Ownership Structure - The offeror consortium currently holds 74.75% of Kangji Medical's shares and has received irrevocable support commitments from some institutional shareholders [6] - After privatization, Zhong Ming and his wife will hold 40% of the ultimate holding company (TopCo) through Fortune Spring ZM and Fortune Spring YG, maintaining their position as the largest shareholders [6] - The funding for the transaction includes HKD 2.08 billion in equity financing and external debt financing, with a total cash consideration of approximately HKD 5.818 billion [6] Group 3: Company Background and Performance - Kangji Medical was established in 2004 and raised HKD 3.6 billion when it listed on the Hong Kong Stock Exchange in 2020, becoming one of the largest healthcare IPOs that year [6] - The company's products cover multiple departments, including obstetrics and gynecology and general surgery, serving over 3,500 hospitals in more than 90 countries and regions, including over 1,000 top-tier hospitals [6] - In 2024, Kangji Medical reported revenue of HKD 1.008 billion and a net profit of HKD 581 million, achieving double growth for five consecutive years, although the growth rate fell below 10% for the first time due to centralized procurement policies [6]

Core Viewpoint - The leading minimally invasive medical device company, Kangji Medical Holdings Limited, is planning to go private through an agreement with Knight Bidco Limited, which will result in the company's delisting from the Hong Kong Stock Exchange [2][4]. Group 1: Privatization Details - The consortium involved in the offer includes notable entities such as the founders, TPG, NewQuest V Fund, and Al-Rayyan Holding, which is fully owned by Qatar Investment Authority [4][9]. - The proposed cancellation price for the shares is set at HKD 9.25 per share, valuing the company at approximately USD 1.4 billion (around HKD 10.99 billion), representing a premium of about 21.7% over the closing price on June 30, 2025 [4][7]. - As of August 13, 2023, Kangji Medical's stock price was HKD 8.50, reflecting a year-to-date increase of 40.28%, although it remains significantly below the IPO price of HKD 13.88 set in June 2020 [4][7]. Group 2: Market Conditions and Company Strategy - The company has faced persistent pressure on its stock price and long-term liquidity issues, limiting its ability to raise funds from the market [7]. - The need to maintain its listing incurs administrative and compliance costs, which, coupled with increased competition and industry uncertainties, has led the company to consider significant investments for sustainable growth [7]. - The necessity of maintaining a public listing has diminished, prompting the decision to pursue privatization [7]. Group 3: Shareholder Dynamics - The founders, Zhong Ming and Shen Tu Yingguang, currently control 52.98% of Kangji Medical and will retain a 40% stake in the ultimate holding company post-privatization, ensuring they remain the largest shareholders [10]. - The acceptance of the privatization proposal by minority shareholders remains uncertain and will depend on future developments [11].

Group 1 - The company, 康基医疗, and the offeror, Knight Bidco Limited, announced a privatization plan to allow the company to focus on long-term strategic decisions, including R&D investments and operational upgrades [1] - The proposed cancellation price is set at HKD 9.25 per share, representing a premium of approximately 21.7% over the closing price of HKD 7.6 as of the undisturbed date (June 30, 2025) [1] - The cancellation price also reflects a premium of about 29.7% over the average closing price of HKD 7.13 per share for the 120 trading days prior to the undisturbed date, and a premium of approximately 47.3% over the average closing price of HKD 6.28 per share for the 360 trading days prior [1] Group 2 - The privatization cash consideration amounts to approximately HKD 58.2 billion, and the offeror does not reserve the right to increase the cancellation price [2] - The offeror is backed by a consortium that includes alternative asset management company TPG [2] - 康基医疗 resumed trading today after being suspended since July 18 [2]

Core Viewpoint - Kangji Medical (9997.HK) is planning to privatize through a cash offer of HKD 9.25 per share, valuing the company at approximately USD 1.4 billion (HKD 11.2 billion) [2] Group 1: Privatization Details - The offer represents a premium of about 9.9% based on the last closing price of HKD 8.42 before suspension on July 17, and a premium of approximately 21.7% based on the closing price of HKD 7.60 on June 30 [2] - An independent board committee has been established to provide voting recommendations to independent shareholders based on an independent financial advisor's report [2] Group 2: Shareholder Structure - The Knight Bidco consortium includes the founders holding 52.98% through Fortune Spring ZM and Fortune Spring YG, and TPG's three funds holding a combined 22.92% [3] - After the transaction, the founders and TPG will hold approximately 40% and 39.6% of the shares in the ultimate holding company, TopCo, respectively [4] Group 3: Company Background and Market Position - Kangji Medical is the largest minimally invasive surgical instrument and consumables platform in China, serving over 3,500 hospitals, including more than 1,000 top-tier hospitals, with a business presence in over 90 countries and regions [4] - The company has faced trading price pressure and liquidity constraints over the past two years, with an average daily turnover rate of only 0.15% in the last 24 months [4] Group 4: Strategic Focus Post-Privatization - Privatization is expected to allow the company to focus on long-term strategic investments rather than short-term performance pressures, with additional resources needed for sales and marketing, innovation technology development, and international market expansion [4]